To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.

dkk 1,275.00 <%= Resources.Global.txtUp %>
Updated 16:20:00
Change % 0.87% Stock price increasing
Change 11.00 Stock price increasing
Volume 213,727
High DKK 1,275.00
Low DKK 1,253.00
Open DKK 1,268.00
ISIN DK0010272202
Prev close DKK 1,264.00
# of shares 60.35M
Market cap 76,946M DKK
Intraday

Market closed
Genmab A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  1,275.00 -1.2% Stock price decreasing 11.9% Stock price increasing 12.1% Stock price increasing 11.6% Stock price increasing 59.1% Stock price increasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2015
1,133
730
764
3,487
3,903
2014
850
265
301
2,032
2,866
2013
664
69
112
660
1,732
2012
485
-117
-487
383
1,693
2011
351
-249
-596
486
1,564
2010
582
-161
-321
1,080
2,482
2009
586
0
-1,011
1,297
2,222
2008
745
-870
-965
2,189
0
2007
530
-437
-383
2,883
0
Powered by TradingView

News about Genmab A/S

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Eisai CO Ltd 52.51 72.2% Stock price increasing 72.2% Stock price increasing 72.2% Stock price increasing 72.2% Stock price increasing 72.2% Stock price increasing 72.2% Stock price increasing
 
Bristol-Myers Squibb Company 56.09 -1.2% Stock price decreasing -4.3% Stock price decreasing 12.1% Stock price increasing -26.2% Stock price decreasing -10.7% Stock price decreasing -4.0% Stock price decreasing
 
Johnson & Johnson 114.61 -0.1% Stock price decreasing -1.1% Stock price decreasing -0.7% Stock price decreasing -6.9% Stock price decreasing 18.2% Stock price increasing -0.5% Stock price decreasing
 
Pfizer Inc 31.96 -2.7% Stock price decreasing -2.7% Stock price decreasing -2.2% Stock price decreasing -12.8% Stock price decreasing 3.7% Stock price increasing -1.6% Stock price decreasing
 
Amgen Inc 155.20 -0.9% Stock price decreasing 3.9% Stock price increasing -4.7% Stock price decreasing -4.7% Stock price decreasing 2.6% Stock price increasing 6.2% Stock price increasing
 
Bavarian Nordic A/S 274.00 -5.2% Stock price decreasing 16.6% Stock price increasing 15.6% Stock price increasing 14.6% Stock price increasing -3.2% Stock price decreasing 10.0% Stock price increasing
 
Merck Kgaa O.N. 103.30 0.3% Stock price increasing 5.6% Stock price increasing 4.4% Stock price increasing 9.0% Stock price increasing 29.4% Stock price increasing 4.2% Stock price increasing
 
Novartis NAM SF 0,50 67.30 -2.5% Stock price decreasing -2.2% Stock price decreasing -2.7% Stock price decreasing -9.0% Stock price decreasing -8.3% Stock price decreasing -2.6% Stock price decreasing
 
Roche Hldg AG GEN 220.30 -2.0% Stock price decreasing 1.3% Stock price increasing 2.4% Stock price increasing -5.2% Stock price decreasing -5.9% Stock price decreasing 1.9% Stock price increasing
 
Biogen Inc 283.00 -1.4% Stock price decreasing -1.2% Stock price decreasing -4.1% Stock price decreasing 8.2% Stock price increasing 3.5% Stock price increasing -0.2% Stock price decreasing
 
Emergent Biosolutions Inc 29.82 -1.9% Stock price decreasing -16.9% Stock price decreasing 3.9% Stock price increasing -4.6% Stock price decreasing -13.9% Stock price decreasing -9.2% Stock price decreasing
 
Bayer AG NA O.N. 102.00 0.9% Stock price increasing 4.5% Stock price increasing 12.5% Stock price increasing 9.8% Stock price increasing 0.9% Stock price increasing 2.9% Stock price increasing
Indices Open
 
OMX Copenhagen 20 CAP 1,033.91 -0.4% Stock price decreasing 3.1% Stock price increasing 0.7% Stock price increasing 2.2% Stock price increasing 9.7% Stock price increasing 1.4% Stock price increasing

Company profile

Genmab is a leading international biotechnology company located in Denmark. They focus on developing medication for cancer treatments. Genmab uses advanced technology to create and develop products to address unmet medical needs.

Peers

Indices Last Change  
OMX C20 CAP 1,033.91 -0.4% Stock price decreasing
71,78,78,78,30,10,14,21,1,29
Instruments Last Change  
Eisai CO Ltd 52.51 -0.9% Stock price decreasing
0,0,0,0,0,0,0,0,0,0
Bristol-Myer.. 56.09 -0.3% Stock price decreasing
70,0,59,30,23,25,18,38,53,30
Johnson & Jo.. 114.61 -0.2% Stock price decreasing
64,54,68,52,21,50,44,28,33,16
Pfizer Inc 31.96 -0.3% Stock price decreasing
38,21,49,50,43,43,32,34,34,0
Amgen Inc 155.20 0.3% Stock price increasing
10,42,96,82,77,70,66,64,66,35
Bavarian Nor.. 274.00 -2.0% Stock price decreasing
75,90,80,70,65,30,25,5,15,5
Merck Kgaa O.. 103.30 1.1% Stock price increasing
2,50,52,58,73,94,73,88,67,73
Novartis NAM.. 67.30 1.2% Stock price increasing
24,64,70,65,65,76,73,65,72,74
Roche Hldg A.. 220.30 0.5% Stock price increasing
50,47,23,10,6,45,28,17,43,80
Biogen Inc 283.00 0.0% Stock price unchanged
0,18,38,45,27,19,22,27,29,8
Emergent Bio.. 29.82 -0.6% Stock price decreasing
31,46,72,67,41,44,44,43,19,0
Bayer AG NA .. 102.00 1.5% Stock price increasing
11,20,37,37,37,60,76,74,86,72

Targets for: Genmab A/S

Ritzau Finans
 
Analyst
Target
Date
Genmab/Goldman: Kursmålet hæves til 1370 kr.
Goldman Sachs
1,370
Yesterday
Genmab/ABG: Løfter kursmål med 400 kr. til 1500 kr.
ABG Sundal Collier
1,500 op
07/06/16
KORR: Genmab/Citi: Hæver kursmål til 1460 kr. fra 1140 kr.
Citigroup
1,460 op
07/06/16
Genmab/Citi: Hæver kursmål til 1460 kr. fra 1140 kr.
Citigroup
1,460 op
07/06/16
Genmab/Danske: Løfter kursmål til 1300 kr. fra 1145 kr.
Danske Bank
1,300 op
23/05/16

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 January 2017 20:08:37
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170103.1 - EUROWEB1 - 2017-01-18 21:08:37 - 2017-01-18 20:08:37 - 1000 - Website: OKAY